Trials / Completed
CompletedNCT05630625
The Drinking Dashboard Study
Dynamic Personalized Feedback for Young Adults With a History of Blackout
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 169 (actual)
- Sponsor
- University of Missouri-Columbia · Academic / Other
- Sex
- All
- Age
- 18 Years – 30 Years
- Healthy volunteers
- Accepted
Summary
This study aims to develop and pilot test the efficacy of a "Drinking Dashboard" providing participants weekly feedback on the risk factors and consequences of blackout.
Detailed description
Approximately 50% of young adults who drink alcohol experience alcohol-induced "blackouts," defined as permanent (en bloc) or temporary (fragmentary) memory loss for events that occurred while they are drinking. This experience of alcohol-induced blackout is associated prospectively with alcohol-related harm, including emergency room visits and sexual coercion, with medical care costs exceeding $469,000 per year. While young adults who have recently experienced a blackout report less favorable evaluations of drinking events and increased motivation to decrease their drinking, they do not actually change their drinking behavior as a result of the blackout alone. Collectively, these data suggest that blackouts may serve as an opportunity for intervention, after which young adults are more likely to respond to alcohol feedback. This R34 aims to develop an intervention tailored to individuals who experience blackouts. In the trial phase, 162 young adults (50% female, ≥50% non-college) who report a history of blackout will be randomly assigned to receive the intervention (n=81) or assessment only (n=81). Outcomes will be assessed immediately post-intervention and at 3-month follow-up.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Drinking Dashboard | Day-level feedback on alcohol use and consequences |
Timeline
- Start date
- 2023-05-30
- Primary completion
- 2024-04-09
- Completion
- 2024-04-09
- First posted
- 2022-11-29
- Last updated
- 2024-09-27
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05630625. Inclusion in this directory is not an endorsement.